Ambrx Biopharma, Inc. is a clinical-stage biologics company, which engages in discovering and developing a novel class of engineered precision biologics (EPBs). Using its proprietary expanded genetic code technology platform, it allows incorporating synthetic amino acids (SAAs) into proteins within living cells. Its product pipeline includes ARX788, ARX517, and ARX305. The company was founded on August 11, 2023 and is headquartered in La Jolla, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Ambrx Biopharma Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Ambrx Biopharma Inc. market cap is $1.77B.
What is the 52-week high for Ambrx Biopharma Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ambrx Biopharma Inc. 52 week high is $28.15 as of September 28, 2025.
What is the 52-week low for Ambrx Biopharma Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ambrx Biopharma Inc. 52 week low is $6.55 as of September 28, 2025.
What is Ambrx Biopharma Inc. stock price today?
Ambrx Biopharma Inc. stock price today is $28.00.
What was Ambrx Biopharma Inc. stock price yesterday?
Ambrx Biopharma Inc. stock price yesterday was $27.98.
What is the PE ratio of Ambrx Biopharma Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Ambrx Biopharma Inc.’s P/E ratio is -13.86.
What is the Price-to-Book ratio of Ambrx Biopharma Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Ambrx Biopharma Inc. P/B ratio is 6.9051.
What is the 50-day moving average of Ambrx Biopharma Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Ambrx Biopharma Inc. 50-day moving average is $27.26.
